Relationship between impaired sensitivity to thyroid hormones and MAFLD with elevated liver enzymes in the euthyroid population

被引:0
作者
Zeng, Haixia [1 ]
Liu, Jianping [1 ,2 ]
Zhang, Yuying [1 ]
机构
[1] Nanchang Univ, Affiliated Hosp 2, Dept Endocrinol & Metab, 1 Minde Rd, Nanchang 330006, Jiangxi, Peoples R China
[2] Inst Study Endocrinol & Metab Jiangxi Prov, Nanchang 330006, Peoples R China
关键词
Sensitivity to thyroid hormones; Metabolic dysfunction-associated fatty liver disease; Free fatty acids; Elevated liver enzymes; NONALCOHOLIC STEATOHEPATITIS; DISEASE; RISK; BETA;
D O I
10.1007/s13410-023-01308-y
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective There is a delicate interplay between thyroid hormones and thyrotropin (TSH) and metabolic homeostasis. However, the role of thyroid hormone sensitivity in metabolic health, particularly in relation to metabolic dysfunction-associated fatty liver disease (MAFLD) and associated complications such as elevated liver enzymes and free fatty acid (FFAs) has not been elucidated in euthyroid populations.Methods A total of 3929 euthyroid adults from the Second Affiliated Hospital, Jiangxi Medical College, Nanchang University were included in this study. Thyroid hormone sensitivity indices were calculated by thyroid feedback quantile-based index (TFQI), TSH index (TSHI) and thyrotropin thyroxine resistance index (TT4RI). Associations between thyroid hormones sensitivities and risk of MAFLD, MAFLD with elevated liver enzymes, MAFLD with elevated FFAs were assessed with logistic regression.Results After adjustment for multiple risk factors, adjusted odds ratio (AOR) of the fourth versus the first TFQI(FT4) quartile for MAFLD, MAFLD with elevated liver enzymes, and MAFLD with elevated FFAs were 1.778 (95% CI 1.378, 2.293), 1.466 (1.105, 1.945), and 1.936 (1.479, 2.534), respectively (all p<0.001). Per 1 SD in TFQI(FT4), ORs increased 2.27 (95% CI 1.74, 2.97) for MAFLD, 2.05 (1.51, 2.78) for MAFLD with elevated liver enzymes, and 2.43 (1.82, 3.24) for MAFLD with elevated FFAs. The other sensitivity to thyroid hormones indices showed similar associations for MAFLD and MAFLD with elevated liver enzymes.Conclusions These findings have important implications for understanding the role of thyroid hormone sensitivity in metabolic health, particularly in relation to MAFLD and associated complications such as elevated liver enzymes and FFAs. TFQI(FT4), TFQI(FT3), TSHI and TT4RI can be used as new indicators for predicting MAFLD and MAFLD with elevated liver enzymes.
引用
收藏
页码:746 / 753
页数:8
相关论文
共 32 条
[1]   Metabolic dysfunction-associated fatty liver disease: a year in review [J].
Alharthi, Jawaher ;
Gastaldelli, Amalia ;
Cua, Ian Homer ;
Ghazinian, Hasmik ;
Eslam, Mohammed .
CURRENT OPINION IN GASTROENTEROLOGY, 2022, 38 (03) :251-260
[2]  
Bano A., 2016, Journal of Clinical Endocrinology & Metabolism, V101, P3204
[3]   Hepatic lipogenesis and cholesterol synthesis in hyperthyroid patients [J].
Cachefo, A ;
Boucher, P ;
Vidon, C ;
Dusserre, E ;
Diraison, F ;
Beylot, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (11) :5353-5357
[4]   TSH-Lowering Effect of Metformin in Type 2 Diabetic Patients Differences between euthyrold, untreated hypothyroid, and euthyrold on L-T4 therapy patients [J].
Cappelli, Carlo ;
Rotondi, Mario ;
Pirola, Ilenia ;
Agosti, Barbara ;
Gandossi, Elena ;
Valentini, Umberto ;
De Martino, Elvira ;
Cimino, Antonio ;
Chiovato, Luca ;
Agabiti-Rosei, Enrico ;
Castellano, Maurizio .
DIABETES CARE, 2009, 32 (09) :1589-1590
[5]   Global Prevalence and Clinical Characteristics of Metabolic-associated Fatty Liver Disease: A Meta-Analysis and Systematic Review of 10 739 607 Individuals [J].
Chan, Kai En ;
Koh, Tiffany Jia Ling ;
Tang, Ansel Shao Pin ;
Quek, Jingxuan ;
Yong, Jie Ning ;
Tay, Phoebe ;
Tan, Darren Jun Hao ;
Lim, Wen Hui ;
Lin, Snow Yunni ;
Huang, Daniel ;
Chan, Mark ;
Khoo, Chin Meng ;
Chew, Nicholas W. S. ;
Kaewdech, Apichat ;
Chamroonkul, Naichaya ;
Dan, Yock Young ;
Noureddin, Mazen ;
Muthiah, Mark ;
Eslam, Mohammed ;
Ng, Cheng Han .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (09) :2691-2700
[6]   Non-alcoholic fatty liver disease across the spectrum of hypothyroidism [J].
Chung, Goh Eun ;
Kim, Donghee ;
Kim, Won ;
Yim, Jeong Yoon ;
Park, Min Jung ;
Kim, Yoon Jun ;
Yoon, Jung-Hwan ;
Lee, Hyo-Suk .
JOURNAL OF HEPATOLOGY, 2012, 57 (01) :150-156
[7]   Non-classic thyroid hormone signalling involved in hepatic lipid metabolism [J].
Cordeiro, Aline ;
Souza, Luana Lopes ;
Einicker-Lamas, Marcelo ;
Pazos-Moura, Carmen Cabanelas .
JOURNAL OF ENDOCRINOLOGY, 2013, 216 (03) :R47-R57
[8]   Thyroid disease and lipids [J].
Duntas, LH .
THYROID, 2002, 12 (04) :287-293
[9]   Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseases [J].
Eslam, Mohammed ;
Ahmed, Aijaz ;
Despres, Jean-Pierre ;
Jha, Vivekanand ;
Halford, Jason C. G. ;
Chieh, Jack Tan Wei ;
Harris, David C. H. ;
Nangaku, Masaomi ;
Colagiuri, Stephen ;
Targher, Giovanni ;
Joshi, Shashank ;
Byrne, Christopher D. ;
Khunti, Kamlesh ;
Nguyen, Mindie H. ;
Gish, Robert G. ;
George, Jacob .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2021, 6 (09) :743-753
[10]   A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement [J].
Eslam, Mohammed ;
Newsome, Philip N. ;
Sarin, Shiv K. ;
Anstee, Quentin M. ;
Targher, Giovanni ;
Romero-Gomez, Manuel ;
Zelber-Sagi, Shira ;
Wong, Vincent Wai-Sun ;
Dufour, Jean-Francois ;
Schattenberg, Joern M. ;
Kawaguchi, Takumi ;
Arrese, Marco ;
Valenti, Luca ;
Shiha, Gamal ;
Tiribelli, Claudio ;
Yki-Jarvinen, Hannele ;
Fan, Jian-Gao ;
Gronbaek, Henning ;
Yilmaz, Yusuf ;
Cortez-Pinto, Helena ;
Oliveira, Claudia P. ;
Bedossa, Pierre ;
Adams, Leon A. ;
Zheng, Ming-Hua ;
Fouad, Yasser ;
Chan, Wah-Kheong ;
Mendez-Sanchez, Nahum ;
Ahn, Sang Hoon ;
Castera, Laurent ;
Bugianesi, Elisabetta ;
Ratziu, Vlad ;
George, Jacob .
JOURNAL OF HEPATOLOGY, 2020, 73 (01) :202-209